Abstract
Correlation was made between the experimental data obtained from different pharmacological tests in animals, and clinical efficiency of a series of antidepressants in 665 treatments of endogenous depressions. The differences in therapeutic activity with regard to the symptomatology were expressed by using an “index of antidepressive action”,
Intensity of adrenomimetic effect estimated by inhibition of noradrenalin uptake, by anti-reserpine and anti-tetrabenazine tests in rats revealed a high correlation with therapeutic efficacy in retarded forms of depression. Intensity of anticholinergic action evaluated by antiphysostigmine, antinicotine and antitremorine tests in animals, correlated with clinical efficacy in anxious and agitated depressions.
Similar content being viewed by others
References
Benešová, O.: The relation of imipramine-like drugs to the cholinergic system. In: Antidepressant drugs, S. Garattini and M. N. J. Dukes (Eds.), pp. 247–254. Amsterdam: Exc. Med. Found. 1967.
—: Mode of action of some psyohotropic drugs. — An experimental study. (In Czech.) Thesis for PhD., Charles University, Prague 1969.
—: Is it possible to predict the clinical effect of antidepressants from experimental data in animals ? Act. nerv. sup. (Praha) 12, 127–128 (1970a).
—: Neurophysiological and biochemical aspects in the action of antidepressant drugs. Act. nerv. sup. (Praha) 12, 226–234 (1970b).
—, Bohdanecký, Z., Grofová, I.: Electrophysiological analysis of the neuroleptic and antidepressive action of psychotropic drugs in rabbits. Int. J. Neuropharmacol. 3, 479–488 (1964a).
— —, Metyšová, J., Metyš, J., Votava, Z.: Pharmacological effects of proheptatriene, a new antidepressant drug of the dibenzocycloheptene group. In: Neuropsychopharmacology, D. Bente and P. B. Bradley (Eds.). Amsterdam: Elsevier 1965 a.
— — — — —: Farmakologické účinky proheptatrienu, nové antidepredivní látky ze skupiny dibenzocycloheptenu. Čas. Lék. čes. 104, 312–315 (1965b).
- - Voronov, I.: Die Beziehung von Psychopharmaka zum adrenergischen und cholinergischen System. Abhandlungen der Deutschen Akademie der Wissenschaft zu Berlin, Klasse für Medizin, Nr. 2, 341–344 (1966).
— —, Votava, Z.: Electrophysiological comparison of the action of imipramine and propazepine. Psychopharmacologia (Berl.) 3, 423–431 (1962).
— — —: Electrophysiological comparism of the action of psychotropic drugs in animals with implanted electrodes. In: Psychopharmacological methods, Z. Votava, M. Horváth and O. Vinař (Eds.), pp. 123–128. Oxford: Pergamon Press 1963.
— — —, Votava, Z.: Über einige zentrale Wirkungen von Prothiaden eines Thymoleptikum aus der Reihe des 6,11-dihydrodibenz(b,e)thiepin Derivate. Arzneimittel-Forschung 14, 100–103 (1964b).
—, Trinerová, I.: The effect of psychotropic drugs on the cholinergic and adrenergic system. Int. J. Neuropharmacol. 3, 473–478 (1964).
Bente, D., Engelmeier, M. P., Heinrich, K., Higgins, H., Schmitt, W.: Klinischpsychopathologische Untersuchungen über die antidepressive Wirkung des zentralen Anticholinergicums Bayer 1433. In: Neuropsychopharmacology, H. Brill (Ed.), pp. 1119–1122. Amsterdam: Exc. Med. Found. 1967.
Berger, F. M.: The significance of laboratory studies in the avaluation and discovery of psychoactive agents in man. Dis. nerv. Syst. 30, 5–10 (1969).
Bickel, M. M., Brodie, B. B.: Structure and antidepressant activity of imipramine analogues. Int. J. Neuropharmacol. 3, 611 (1964).
Bojanovský, J., Chloupková, K.: The use of orphenadrine in depressive patients. (In Czech.) Act. nerv. sup. (Praha) 3, 230 (1961).
Callingham, B. A.: The effects of imipramine and related compounds on the uptake of noradrenaline into sympathetic nerve endings. In: Antidepressant drugs. S. Garattini and M. N. G. Dukes (Eds.), pp. 37–43. Amsterdam: Elsevier 1967.
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of antidepressant drugs on the depletion of introneuronal brain 5-hydroxytryptamine storage caused by 4-methyl-y-ethyl-metatyramine. Europ. J. Pharmacol. 5, 357–366 (1969a).
— — — —: Effect of some antidepressant drugs on the depletion of intra-neuronal brain catecholamines stores caused by 4,alfa-dimethyl-meta-tyramine. Europ. J. Pharmacol. 5, 367–373 (1969b).
Corrodi, H., Fuxe, K.: Decreased turnover in central FHT nerve. Terminals induced by antidepressant drugs of the imipramine type. Europ. J. Pharmacol. 7, 56–59 (1969).
Garattini, S., Giachetti, A., Jori, A., Pieri, L., Valzelli, L.: Effect of imipramine, amitriptyline and their monomethyl derivatives on reserpine activity. J. Pharmacol. exp. Ther. 14, 509 (1962).
—, Jori, A.: Interactions between imipramine-like drugs and reserpine in body temperature. In: Antidepressant drugs. S. Garattini and M. N. G. Dukes (Eds.), pp. 179–193. Amsterdam: Exc. Med. Found. 1967.
Gilette, J. H., Dingel, J. V., Sulser, F., Kuntzman, R., Brodie, B. B.: Isolation from the rat brain of a metabolic product, desmethylimipramine that mediates the antidepressant activity of imipramine. Experientia (Basel) 17, 417 (1961).
Hjelte, H., Richter, W.: Is the secondary amine function necessary for antireserpine activity in dibenzocycloheptenes ? In: Antidepressant drugs. S. Garattini and M. N. Dukes (Eds.), pp. 23–27. Amsterdam: Exc. Med. Found. 1967.
Jacobsen, S. E.: The effect of benactyzine on stress induced behavior in the cat. Acta pharmacol. (Kbh.) 111, 135 (1955).
Jensen, O.: Benactysinterapi ved psychoneuroser. Nord. Med. 57, 428 (1957).
Ilyutchenok, P. Yu., Yelizayeva, A. G.: Cholinergic mechanism of the emotional reaction of fear. Zh. vyssh. nerv. Dejat. Pavlova 17, 330–337 (1967).
Iversen, L. L.: Inhibition of noradrenaline uptake of drugs. J. Pharm. Pharmacol. 17, 62–64 (1965).
Kielholz, P.: Der heutige Stand der medikamentösen Depressionsbehandlung. Act. nerv. sup. (Praha) 9, 53–57 (1967).
Lapin, I.P., Oxenkrug, G.F.: Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 18, 132–136 (1969).
Metyš, J., Metyšová, J.: Relationship between antireserpine and central cholinolytic effects of imipramine-like antidepressants. In: Antidepressant drugs. S. Garattini and M. N. G. Dukes (Eds.), pp. 253–265. Amsterdam: Exc. Med. Found. 1967.
Metyšová, J., Metyš, J., Votava, Z.: Attempt to differentiate thymoleptics and neuroleptics by means of their influence on the effect of reserpine. Int. J. Neuropharmacol. 3, 361–368 (1964).
Michaelis, W., Stille, G.: Demethylation of imipramine and antitetrabenazine effect in the catalepsy and ptosis test. Life Sci. 7, 99–106 (1968).
Morpurgo, C., Theobald, W.: Influence of imipramine-like compounds and chlorpromazine on the reserpine-hypothermie in mice and the amphetamine-hyperthermie in rats. Med. Pharmacol. exp. 12, 226–232 (1965).
Náhunek, K.: On the antidepressive effect of phenothiazines and imipramine substances. Scr. med. Fac. Med. Brun. 39, 141 (1966a).
—: The antidepressive action of phenothiazines and imipramine substances. Act. nerv. sup. (Praha) 8, 353 (1966b).
- Index of antidepressive effects of some neuroleptics and tricyclic thymoleptica (in Czech). De psychiatria progrediente. Sborn. KUNZ (Plzeň), 772 (1968).
—: Zur Qualität und Qualität der therapeutischen Wirkung von Neuroleptika, trizyklischen Thymoleptika und Konvulsionsmethoden bei endogenen Depressionen. Int. Pharmacopsychiat. 2, 140–147 (1969a).
—: Zur antidepressiven Wirkung von Neuroleptika und tricyclischen Thymoleptika bei endogenen Depressionen. The Present Status of Psychotropic Drugs. A. Cerletti, F. Bovet (Eds.), pp. 493–494. Amsterdam: Exc. Med. Found. 1969b.
Náhunek, K., Mišurec, J., Rodová, A., Ingrová, L., Bártová, D.: Some clinical and experimental experience with proheptatrien. Act. nerv. sup. (Praha) 7, 291 (1965).
— — —: Clinical experience with nortriptyline in endogenous depression. Comparison with other antidepressive drugs and its influence on the photomyoclonic threshold. Scr. med. Fac. Med. Brun. 6–7, 321 (1969).
- - - Švestka, J.: Klinische Erfahrungen mit Prothiaden and Northiaden bei endogenen Depressionen, S. 85–88. III. Donau Symposium für Psychiatrie 15.–18.5. 1968.
— —, Švestka, J.: Dibenzepin in the treatment of endogenous depression. Act. nerv. sup. (Praha) 12, 263 (1970b).
—, Švestka, J., Mišurec, J.: Melitracen (Trausabun). A clinical and experimental study. Scr. med. Fac. Med. Brun. 3–4, 81–88 (1967).
— —, Rodová, A.: Clinical test of protriptylin in endogenous and involutional depression. Act. nerv. sup. (Praha) 12, 235 (1970a).
— — —: Clinical experience with chlorimipramine in endogenous depressions (in Czech). Act. nerv. sup. (Praha) 12, 64 (1970c).
Pöldinger, W.: Medikamentöse Depressionsbehandlung und Depressionsforschung. Wien. med. Wschr. 117, 69–75 (1967).
Protiva, M., Hnevsová-Seidlová, V., Vejdľek, Z., Jirkovský, J., Votava, Z., Metyšová, J.: A new group of tranquilizers: derivatives of 2,3;6,7-dibenzosuberane. J. med. pharm. Chem. 4, 411 (1961).
—, Rajšner, M., Seidlová, V., Adlerová, E., Vejdělek, E.: Derivate des 6,11-Dihydrodibenz(b,c)thiepine, eine neue Gruppe von psychotropen Substanzen. Experientia (Basel) 18, 326–340 (1962).
Rajšner, M., Protiva, M.: Syntetická ataraktika VII. 11-(dimethylaminopropyliden)-6,11-dihydrodibenz(b,c)thiepin. Čs. Farm. 11, 404–409 (1962).
Rodová, A., Náhunek, K., Švestka, J.: Clinical experience with trimeprimine in endogenous and involutional depressions. Act. nerv. sup. (Praha) 12, 261 (1970a).
—, Švestka, J., Náhunek, K.: Clinical experience with desimipramine in endogenous and involutional depressions (in Czech). Act. nerv. sup. (Praha) 12, 65 (1970b).
Schmitt, H., Schmitt, H.: Valeur de la pharmakologie prévisionelle dans le domaine des antidépresseurs dérivés de l'iminobenzyle. Thérapie 21, 653–674 (1966).
Sereyski, M. J.: Therapy of psychic diseases. Moskva: Medgiz 1948.
Spencer, P. S. J.: Antagonism of hypothermia in the mouse by antidepressants. In: Antidepressant drugs. S. Garattini and M. N. O. Dukes (Eds.), pp. 194–204. Amsterdam: Exc. Med. Found. 1967.
Stille, G., Neuner, H., Eichenberger, E.: Ein pharmakologischer Vergleich klinisch gebräuchlicher Antidepressiva unter besonderer Berücksichtigung von Noveril (HF-1927 Wander). Schweiz. med. Wschr. 95, 366–372 (1965).
Sulser, F., Bickel, M. H., Brodie, B. B.: On mechanism of the anti-depressant action of imipramine. Proc. I. Int. Pharmacol. Meeting, vol. 8, p. 123 (1961).
—, Watts, J., Brodie, B. B.: On the mechanism of antidepressant action of imipramine-like drugs. Ann. N. Y. Acad. Sci. 96, 229 (1962).
Šedivec, V., Váňa, J.: The treatment of depressive states with orphenadrine. Act. nerv. sup. (Praha) 3, 23 (1961).
Vinař, O.: Rating Scale FKD. Act. nerv. sup. (Praha) 8, 409 (1966a).
—: Scale for rating side effects during psychiatric pharmacotherapy. Act. nerv. sup. (Praha) 8, 411 (1966b).
—, Vojtěchovský, M., Vinařová, M.: Benaktycin, a new drug for the treatment of anxiety states (in Czech). Farmakoterap. Zprávy 4, 182 (1958).
Vojtěchovský, M.: Position of the central cholinolytics among psychopharmacological agents (in Czech). Farmakoterap. Zprávy 10, 379–412 (1964).
Votava, Z., Metyšová, J., Metyš, J., Benešová, O., Bohdanecký, Z.: Comparison of pharmacological effects of some antidepressants of imipramine type and their desmethyl-derivatives. In: Neuropsychopharmacology. D. Bente and P. B. Bradley (Eds.), pp. 395–401. Amsterdam: Elsevier 1965.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benešová, O., Náhunek, K. Correlation between the experimental data from animal studies and therapeutical effects of antidepressant drugs. Psychopharmacologia 20, 337–347 (1971). https://doi.org/10.1007/BF00403565
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403565